Journal
JCI INSIGHT
Volume 5, Issue 9, Pages -Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.132747
Keywords
-
Categories
Funding
- JSPS KAKENHI [16H07049, 18K15892, 17K09582, 20K08426, 17H03977, 18K19405, 15H04815, 19H03655]
- Takeda Science Foundation
- Uehara Memorial Foundation
- Japan Foundation for Applied Enzymology (Vascular Biology of Innovation
- VBIC)
- YOKOYAMA Foundation for Clinical Pharmacology [YRY-1911]
- MSD Life Science Foundation
- Public Interest Incorporated Foundation
- AMED CREST grant [JP19gm0910013]
- AMED grant [19ek0109339h0002]
- Grants-in-Aid for Scientific Research [20K08426, 19H03655, 18K15892, 18K19405, 15H04815, 16H07049, 17K09582, 17H03977] Funding Source: KAKEN
Ask authors/readers for more resources
Doxorubicin (DOX), a chemotherapeutic agent, induces a cardiotoxicity referred to as doxorubicin-induced cardiomyopathy (DIC). This cardiotoxicity often limits chemotherapy for malignancies and is associated with poor prognosis. However, the molecular mechanism underlying this cardiotoxicity is yet to be fully elucidated. Here, we show that DOX downregulated glutathione peroxidase 4 (GPx4) and induced excessive lipid peroxidation through DOX-Fe2+ complex in mitochondria, leading to mitochondria-dependent ferroptosis; we also show that mitochondria-dependent ferroptosis is a major cause of DOX cardiotoxicity. In DIC mice, the left ventricular ejection fraction was significantly impaired, and fibrosis and TUNEL+ cells were induced at day 14. Additionally, GPx4, an endogenous regulator of ferroptosis, was downregulated, accompanied by the accumulation of lipid peroxides, especially in mitochondria. These cardiac impairments were ameliorated in GPx4 Tg mice and exacerbated in GPx4 heterodeletion mice. In cultured cardiomyocytes, GPx4 overexpression or iron chelation targeting Fe2+ in mitochondria prevented DOX-induced ferroptosis, demonstrating that DOX triggered ferroptosis in mitochondria. Furthermore, concomitant inhibition of ferroptosis and apoptosis with ferrostatin-1 and zVAD-FMK fully prevented DOX-induced cardiomyocyte death. Our findings suggest that mitochondria-dependent ferroptosis plays a key role in progression of DIC and that ferroptosis is the major form of regulated cell death in DOX cardiotoxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available